Clinical Trial Update: Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy [Phase 2]

View source ↗

Summary

Phase II dose response study of NPO-13 in patients undergoing total colonoscopy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowel Disease

Drugs mentioned

• NPO-13

Snippet

Sponsor: Nihon Pharmaceutical Co., Ltd | Conditions: Bowel Disease | Phase 2 | Status: COMPLETED